Biogen, AbbVie once-monthly MS injection wins Us Fda approval

Biogen, AbbVie once-monthly MS injection wins Us Fda approval


REUTERS: The U.S. Food and Drug Administration on Friday approved a once-monthly injection for multiple sclerosis from Biogen Inc and AbbVie Inc. The self-administered, under-the-skin injection, Zinbryta, is designed to treat adults with relapsing forms of the disease.



from Biotech News